166 related articles for article (PubMed ID: 23940416)
1. Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly(lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling pathway.
Hou CC; Tsai TL; Su WP; Hsieh HP; Yeh CS; Shieh DB; Su WC
Int J Nanomedicine; 2013; 8():2689-707. PubMed ID: 23940416
[TBL] [Abstract][Full Text] [Related]
2. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
4. Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine.
Zhang L; Xu Y; Cao W; Xie S; Wen L; Chen G
Int J Nanomedicine; 2018; 13():479-492. PubMed ID: 29403277
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
6. Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Bharali DJ; Yalcin M; Davis PJ; Mousa SA
Nanomedicine (Lond); 2013 Dec; 8(12):1943-54. PubMed ID: 23448245
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
Banstola A; Duwa R; Emami F; Jeong JH; Yook S
Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
[TBL] [Abstract][Full Text] [Related]
10. Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells.
Menon JU; Tumati V; Hsieh JT; Nguyen KT; Saha D
J Biomed Mater Res A; 2015 May; 103(5):1632-9. PubMed ID: 25088162
[TBL] [Abstract][Full Text] [Related]
11. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Calcium Hydroxide-loaded Poly(Lactic-co-glycolic Acid) Biodegradable Nanoparticles in the
Chaiyosang P; Mahatnirunkul T; Leelapornpisid W
J Contemp Dent Pract; 2023 Jun; 24(6):351-356. PubMed ID: 37534500
[TBL] [Abstract][Full Text] [Related]
13. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer.
Cai J; Qian K; Zuo X; Yue W; Bian Y; Yang J; Wei J; Zhao W; Qian H; Liu B
J Biomater Appl; 2019 May; 33(10):1394-1406. PubMed ID: 30952195
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway.
Wang Y; Li J; Chen JJ; Gao X; Huang Z; Shen Q
Mol Pharm; 2017 Apr; 14(4):1120-1132. PubMed ID: 28291364
[TBL] [Abstract][Full Text] [Related]
15. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
16. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
17. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line.
Chopra D; Ray L; Dwivedi A; Tiwari SK; Singh J; Singh KP; Kushwaha HN; Jahan S; Pandey A; Gupta SK; Chaturvedi RK; Pant AB; Ray RS; Gupta KC
Biomaterials; 2016 Apr; 84():25-41. PubMed ID: 26803409
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
19. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
[TBL] [Abstract][Full Text] [Related]
20. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A
Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
